The dysregulation of Bcl-2 family proteins, which includes overexpression of antiapoptotic members and decreased expression of proapoptotic members, is required for cancer development, contributes to apoptotic resistance, and is associated with chemoresistance, as well [22, 23]. This evidence concerns the gene BCL2 and cancer.